01608oam 2200421 a 450 991070224050332120121031121556.0(CKB)5470000002425745(OCoLC)695394179(EXLCZ)99547000000242574520110106d1985 ua 0engurbn|||||||||txtrdacontentcrdamediacrrdacarrierAssertion without empirical basis[electronic resource] an econometric appraisal of Monetary trends in ... the United Kingdom, by Milton Friedman and Anna J. Schwartz /by David F. Hendry and Neil R. EricssonRev. Dec. 1985.[Washington, D.C.] :[Board of Governors of the Federal Reserve System],[1985]1 online resource (62 pages) illustrationsInternational finance discussion papers ;number 270Title from title screen (viewed on Oct. 31, 2012).Includes bibliographical references (pages 58-62).Assertion without empirical basis Econometric modelsDemand for moneyGreat BritainMathematical modelsEconometric models.Demand for moneyMathematical models.Hendry David F89336Ericsson Neil R89175Board of Governors of the Federal Reserve System (U.S.)CUSCUSGPOBOOK9910702240503321Assertion without empirical basis3438731UNINA04687nam 2201489z- 450 991058593550332120220812(CKB)5600000000483130(oapen)https://directory.doabooks.org/handle/20.500.12854/91208(oapen)doab91208(EXLCZ)99560000000048313020202208d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierAdvances in Antifungal Development: Discovery of New Drugs and Drug RepurposingBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (282 p.)3-0365-4768-1 3-0365-4767-3 This reprint describes recent advances made in the field of antifungal development, especially the discovery of new drugs and drug repurposing. The articles presented in this book provide useful information and insight for the development of new antifungal drugs or intervention strategies. The identification of new, safe molecules, and cellular targets, as well as the elucidation of their antifungal mechanisms of action, will further the effective control of fungal pathogens, especially those resistant to current therapeutic agents.Advances in Antifungal DevelopmentBiology, life sciencesbicsscResearch & information: generalbicssc3-phenyl-1H-indazoleAcanthamoebaAcanthamoeba keratitisacetylsalicylic acid (ASA, aspirin)all-trans retinoic acidanticandidal activityantifungalantifungal drugsantifungalsAspergillus spp.azoleazolesbeta-glucanbiological synthesiscandidaCandidacandida albicansCandida aurisCandida spp.candidosiscanestenCAP64capsulecell integritycell lysiscell separationcell wallclotrimazoleCryptococcuscystcytokinesisdermatophytesdrugdrug delivery systemsdrug designdrug discoverydrug repurposingdrug targetsechinocandin drugsechinocandin resistanceechinocandinsemerging fungiFelis catusfission yeastFks resistance hot spotsfree-living amebafungiGalleria mellonella modelhost-directed drug therapyhydrazonesindazoleinvasive aspergillosis treatmentinvasive fungal infectionsisavuconazonium sulfateMalassezia spp.marinemembrane potential (ΔΨM)microbiologymultidrug resistancemycologymyconanotechnologymycosisn/ananoparticlesnatural productsnew targetsonychomycosisphotodynamic treatmentphotosensitiserpolycationspolyenespyrazolequinonesrepositioningresistanceretinoidsseptationsporotrichosissynergytherapeutic alternativesultrastructurevaginal healthvaginitisviral infectionsvulvovaginalyeast infectionyeastszoonosesβ(1,3)-D-glucan synthaseBiology, life sciencesResearch & information: generalKim Jong Heonedt1318507Cheng Luisa WedtLand KirkwoodedtKim Jong HeonothCheng Luisa WothLand KirkwoodothBOOK9910585935503321Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing3033342UNINA